Gastroparesis and SIBO: The Overlap That’s Making Your Symptoms Worse
If you have gastroparesis, you already know the basics: your stomach empties too slowly, and that creates a cascade of distressing symptoms like nausea, bloating, and that unbearable sense of fullness after just a few bites. But here's something you may not have heard about, and something that researchers at Cedars-Sinai are paying close attention to: for many gastroparesis patients, the stomach isn't the whole story.
A growing body of research suggests that up to 41% of people with gastroparesis also have some form of microbial overgrowth in their small intestine, and those overgrowths may be making their symptoms substantially worse. Understanding the connection between these two conditions explains why some patients don't respond well to standard gastroparesis treatment. And it opens the door to a more complete picture of what's actually happening in the gut.
Table of Contents
-
What Happens in Your Stomach Doesn’t Stay in Your Stomach
-
When Your Gut Slows, Bacteria Take Over
-
How Common Is the Gastroparesis and SIBO Overlap?
-
The Methane Problem: A Double Hit for Gastroparesis Patients
-
Why Did This Start? The Food Poisoning Connection
-
Getting the Full Picture: Why Breath Testing Matters
-
The Question of Root Cause
-
What This Means for Gastroparesis Patients
-
Gastroparesis and SIBO FAQ
What Happens in Your Stomach Doesn’t Stay in Your Stomach
To understand why gastroparesis and microbial overgrowth so often go hand in hand, it helps to think of the gastrointestinal tract not as a series of independent compartments, but as one continuous system with shared plumbing and shared wiring.
Dr. Mark Pimentel, executive director of the Medically Associated Science and Technology (MAST) Program at Cedars-Sinai Medical Center, has conducted decades of research on the interconnectedness of gastrointestinal disorders. In a presentation to the Gastroparesis Patient Association for Cures and Treatments (GPAC), he explained that there is no dividing line in the nervous system of the gut. "Inevitably, anybody with gastroparesis, their small bowel is also affected," he said. "Inevitably, anybody with a small bowel neuropathy, their stomach is also affected. So there is no dividing line that says gastroparesis only, not small bowel, or small bowel only and not stomach — because they're in continuity."
That's a critical point. Dr. Pimentel explains that when dysfunction impairs the stomach, the consequences almost always extend into the small intestine. And when the small intestine isn’t moving normally, it becomes more susceptible to microbial overgrowth.
When Your Gut Slows, Bacteria Take Over
The small intestine normally contains relatively few bacteria compared to the colon. That's by design. A healthy gut relies on a combination of stomach acid, immune activity, and rhythmic muscular movement to keep bacterial populations in check.
When movement slows down, that balance breaks down. Think of a slow drain in a sink. When water doesn't flow freely, residue builds up. The same principle applies in the gut: when the natural cleansing action of the intestinal tract is impaired, bacteria that normally exist in small numbers begin to multiply.
This is Small Intestinal Bacterial Overgrowth, or SIBO, and according to Dr. Pimentel, it is never random. "SIBO is always there because of some problem that happened," he explained. "Anything that slows the intestinal tract can cause SIBO."
In this context, Dr. Pimentel is using "SIBO" in the broad, conversational sense, as shorthand for the overgrowth that develops when motility breaks down. More precisely, microbial overgrowth is now understood in terms of three distinct patterns, each defined by the dominant gas produced during fermentation.
-
SIBO (Small Intestinal Bacterial Overgrowth): Driven primarily by bacteria, particularly E. coli and Klebsiella pneumoniae, that produce hydrogen gas during fermentation.
-
IMO (Intestinal Methanogen Overgrowth): Driven by archaea, specifically Methanobrevibacter smithii, which produce methane gas. IMO is strongly associated with constipation.
-
ISO (Intestinal Sulfide Overproduction): Driven by sulfate-reducing organisms that produce hydrogen sulfide. ISO is closely linked to diarrhea. And because hydrogen sulfide is not included on most traditional breath tests, it may not be picked up unless a three-gas test is used.
How Common Is the Gastroparesis and SIBO Overlap?
The research on this is striking. A 2023 systematic review and meta-analysis published in Gastroenterology and Hepatology from Bed to Bench found that among patients with confirmed gastroparesis, the pooled prevalence of SIBO was 41 percent. In other words, over two-fifths of gastroparesis patients studied also had bacterial overgrowth.
And that number may actually be an undercount. As Dr. Pimentel pointed out in his GPAC presentation, breath testing in gastroparesis patients is inherently tricky: if the substrate drink used in the test can't clear the stomach quickly enough, breath results may appear falsely normal. "So if we're seeing 40 percent positive with gastroparesis using breath tests," he said, "it's likely much higher than that, because in some of those patients, the sugar just never gets out of the stomach."
The Methane Problem: A Double Hit for Gastroparesis Patients
Of the three gas types, methane may be the most important, and the most overlooked in people with gastroparesis.
In a landmark study published in American Journal of Physiology: Gastrointestinal and Liver Physiology, Dr. Pimentel and his colleagues demonstrated that methane gas actively slows intestinal transit. When methane was infused into the small intestine of animals, transit time slowed by an average of 59 percent. Methane doesn't work by paralyzing the gut. Instead, it causes the gut to contract and grip, holding material in place rather than moving it forward.
The implications for gastroparesis are significant. If a patient already has delayed gastric emptying and also has high methane levels from IMO, those two conditions may be compounding each other. The stomach is slow, and now the intestine is squeezing rather than flowing. Dr. Pimentel put it plainly: "If you have gastroparesis and methane, your gastroparesis is going to be worse. If you have very high methane, your stomach is going to be slower."
This is also why bloating deserves closer attention in gastroparesis patients. The stomach is a relatively small organ, and its ability to expand enough to cause visible abdominal distension is limited. When bloating is severe enough to visibly distend the abdomen, the small intestine is likely involved. That's not a diagnosis, but it is a signal worth investigating.
Why Did This Start? The Food Poisoning Connection
For idiopathic gastroparesis, the kind with no obvious cause like diabetes or surgery, one possible explanation is that it began with an infection. In fact, infections are a recognized cause of gastroparesis, though they are still not as well understood or routinely discussed as some other causes.
Dr. Pimentel and the MAST Program have spent years building the case that a significant subset of IBS (and, by extension, possibly some cases of idiopathic gastroparesis) may be post-infectious in origin. The basic idea is this: certain foodborne bacteria produce toxins that trigger an immune response. In some patients, that response may also target vinculin, a structural protein involved in gut neuromuscular function. When that happens, motility can be disrupted, and the conditions for microbial overgrowth may follow.
“We believe that this neuropathy caused by these antibodies, caused by food poisoning, could be what causes SIBO and IBS,” Pimentel said.
Research has found that higher anti-vinculin antibody levels correlate with lower densities of Interstitial Cells of Cajal (ICC) in the stomach, which help coordinate the electrical rhythms that drive motility. Because ICC loss is already well established as a feature of gastroparesis, some researchers believe a post-infectious mechanism like this one may be relevant in at least a subset of cases. It remains an open and active area of investigation.
Getting the Full Picture: Why Breath Testing Matters
Breath testing in gastroparesis patients comes with a specific complication. Standard breath testing works by having the patient drink a sugar substrate, usually lactulose or glucose, which gut microbes ferment into gases measured in the breath. In gastroparesis patients, lactulose may offer an advantage because it is not absorbed and can travel farther through the small intestine, whereas glucose is absorbed earlier and may miss more overgrowth that occurs farther down the line.
The catch is that if lactulose takes too long to clear the stomach, the gas reading may appear flat even when overgrowth is present. Dr. Pimentel has noted that interpreting breath test results in the context of the patient’s full clinical picture, rather than applying a rigid cutoff, can improve accuracy. A delayed rise in gas levels isn’t necessarily a failed test. It may itself be a meaningful finding.
The other limitation of conventional breath testing is that most tests only measure two gases: hydrogen and methane. Hydrogen sulfide has historically been invisible to standard two-gas tests. Measuring all three gases matters because each points to a different type of overgrowth with different clinical implications.
The Trio-Smart Breath Test measures all three gases in a single at-home collection. It is processed at a CLIA-certified lab and can be ordered with either lactulose or glucose as the substrate. For gastroparesis patients, lactulose is generally the better choice for the reasons described above, though substrate selection should be guided by a treating physician. For gastroparesis patients whose symptoms aren't fully explained by delayed gastric emptying alone, knowing which gases are elevated and which aren't can add clinically useful context.
The Question of Root Cause
It's worth pausing to emphasize something Dr. Pimentel returns to repeatedly in his work: the goal isn't just to manage symptoms, it’s to understand what's actually causing them.
"Our philosophy is root cause, root cause, root cause," he said. "I do not like the approach where we're just told to take a laxative for constipation or an antidiarrheal for diarrhea. I think we need to figure out the causes."
For gastroparesis patients with suspected microbial overgrowth, that means testing, not assuming. It means asking whether the bloating is coming from the stomach, or from the small intestine. It means asking whether methane is slowing transit beyond what delayed gastric emptying alone would explain. And increasingly, it means asking whether a post-infectious immune response may be part of why the gut isn't functioning properly to begin with.
For patients whose history includes a possible triggering infection, or who have IBS-like symptoms alongside their motility disorder, it may also be worth asking a physician whether antibody testing is appropriate. IBS-Smart is an at-home blood test that measures two antibodies associated with post-infectious gut dysfunction, and for the right patient, it may help clarify whether that mechanism is part of the picture.
What This Means for Gastroparesis Patients
None of this means that every gastroparesis patient has microbial overgrowth, or that treating overgrowth will resolve gastroparesis. The relationship is real, but it’s not simple. So, when symptoms persist or they don't fit neatly into a single diagnosis, microbial overgrowth is worth investigating.
The gut is one system. Motility and the microbiome influence each other in ways that are still being mapped, but the connection is real and the research is established. For anyone looking for a better picture of what is causing their symptoms, like bloating, constipation, diarrhea, and abdominal discomfort, testing for microbial overgrowths like SIBO, IMO and ISO is a good place to start.
Gastroparesis and SIBO FAQ
What causes idiopathic gastroparesis?
Idiopathic gastroparesis means the cause is unknown. In some patients, researchers suspect a post-infectious trigger, such as food poisoning or another gastrointestinal infection that disrupts gut motility.
Can gastroparesis cause SIBO?
Gastroparesis and SIBO often occur together. When stomach emptying is delayed, motility problems may also affect the small intestine, increasing the risk of bacterial overgrowth.
What is the difference between SIBO, IMO, and ISO?
SIBO, IMO, and ISO are all types of microbial overgrowth, but they involve different organisms and different gases. SIBO is linked to hydrogen, IMO to methane, and ISO to hydrogen sulfide.
Can SIBO or IMO make gastroparesis worse?
They can. Methane, the gas associated with IMO, has been shown to slow intestinal transit, so microbial overgrowth may add to the motility problems already present in gastroparesis.
What is a three-gas breath test for SIBO?
A three-gas breath test like Trio-Smart measures hydrogen, methane, and hydrogen sulfide after a sugar substrate is consumed. It provides a more complete view of microbial overgrowth than standard two-gas breath testing.
Is lactulose or glucose better for breath testing in gastroparesis?
Lactulose is often preferred in gastroparesis because it is not absorbed and can travel farther through the small intestine. The best substrate depends on the clinical situation and should be discussed with a physician.
What is the best breath test for gastroparesis patients with bloating?
For gastroparesis patients with bloating, abdominal distension, constipation, diarrhea, or mixed bowel symptoms, a three-gas breath test may provide more useful information by measuring hydrogen, methane, and hydrogen sulfide.
What is IBS-Smart?
IBS-Smart is a blood test that measures antibodies associated with post-infectious gut dysfunction. It may be relevant for patients whose symptoms may have begun after food poisoning or a gastrointestinal illness.